Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

1.

Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score.

Gasparini M, Klersy C, Leclercq C, Lunati M, Landolina M, Auricchio A, Santini M, Boriani G, Proclemer A, Leyva F.

Eur J Heart Fail. 2015 Apr 23. doi: 10.1002/ejhf.269. [Epub ahead of print]

PMID:
25903349
2.

New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in bradycardia patients: Results from the MINERVA randomized multicenter international trial.

Padeletti L, Pürerfellner H, Mont L, Tukkie R, Manolis AS, Ricci R, Inama G, Serra P, Scheffer MG, Martins V, Warman EN, Vimercati M, Grammatico A, Boriani G; MINERVA Investigators.

Heart Rhythm. 2015 Apr 11. pii: S1547-5271(15)00428-2. doi: 10.1016/j.hrthm.2015.04.015. [Epub ahead of print]

PMID:
25869753
3.

Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD.

Corzani A, Ziacchi M, Biffi M, Diemberger I, Martignani C, Boriani G.

Indian Heart J. 2015 Jan-Feb;67(1):56-9. doi: 10.1016/j.ihj.2015.01.001. Epub 2015 Feb 12.

PMID:
25820052
4.

Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?

Boriani G.

Europace. 2015 May;17(5):674-6. doi: 10.1093/europace/euv031. Epub 2015 Mar 23. No abstract available.

PMID:
25805157
5.

Management of atrial fibrillation in bradyarrhythmias.

Boriani G, Padeletti L.

Nat Rev Cardiol. 2015 Mar 17. doi: 10.1038/nrcardio.2015.30. [Epub ahead of print] Review.

PMID:
25781413
6.

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.

Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.

Eur J Heart Fail. 2015 Mar 2. doi: 10.1002/ejhf.254. [Epub ahead of print]

PMID:
25727992
7.

Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.

Boriani G, Manolis AS, Tukkie R, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, Gulizia M, Samoilenko IV, Wolff C, Holbrook R, Gavazza F, Padeletti L; MINERVA Investigators.

Heart Rhythm. 2015 Feb 19. pii: S1547-5271(15)00196-4. doi: 10.1016/j.hrthm.2015.02.017. [Epub ahead of print]

PMID:
25701774
8.

Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice.

Boriani G, Lane DA, Windecker S, Huber K, Kirchhof P, Lip GY.

Europace. 2015 Feb 12. pii: euu303. [Epub ahead of print] No abstract available.

PMID:
25678602
9.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, John Camm A; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators).

Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.

PMID:
25602175
10.

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement.

Capodanno D, Lip GY, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet JP, Valgimigli M, Byrne RA.

EuroIntervention. 2015 Jan;10(9):1015-21. doi: 10.4244/EIJV10I9A174. No abstract available.

PMID:
25599718
11.

Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants.

Boriani G, Cimaglia P, Fantecchi E, Mantovani V, Ziacchi M, Valzania C, Martignani C, Biffi M, Diemberger I.

J Cardiovasc Med (Hagerstown). 2015 Jan 14. [Epub ahead of print]

PMID:
25575278
12.

The epidemiologic threat of atrial fibrillation: need for secondary, primary, and primordial prevention.

Boriani G.

Chest. 2015 Jan;147(1):9-10. doi: 10.1378/chest.14-1565. No abstract available.

PMID:
25560853
13.

Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, Sinagra G, Petrescu L, Tavazzi L, Maggioni AP, Lip GY.

Am J Med. 2015 May;128(5):509-518.e2. doi: 10.1016/j.amjmed.2014.11.026. Epub 2014 Dec 20.

PMID:
25534423
14.

Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization.

Ziacchi M, Diemberger I, Biffi M, Martignani C, Bertini M, Rocchi G, Biagini E, Graziosi M, Mazzotti A, Rapezzi C, Boriani G.

J Cardiovasc Med (Hagerstown). 2014 Dec 2. [Epub ahead of print]

PMID:
25469730
15.

BLOCK HF: how far does it extend indications for cardiac resynchronization therapy?

Boriani G, Ziacchi M, Diemberger I, Biffi M, Martignani C, Leyva F.

J Cardiovasc Med (Hagerstown). 2014 Nov 15. [Epub ahead of print]

PMID:
25405947
16.

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).

Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Boriani G.

Eur Heart J. 2014 Dec 14;35(47):3365-76. doi: 10.1093/eurheartj/ehu374. Epub 2014 Aug 31.

PMID:
25176940
17.

Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia?

Boriani G, Valzania C, Biffi M, Diemberger I, Ziacchi M, Martignani C.

Curr Pharm Des. 2015;21(5):659-66.

PMID:
25175089
18.

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.

Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U, Lip GY, Potpara T, Fauchier L, Sticherling C, Roffi M, Widimsky P, Mehilli J, Lettino M, Schiele F, Sinnaeve P, Boriani G, Lane D, Savelieva I.

Europace. 2014 Nov;16(11):1655-73. doi: 10.1093/europace/euu208. Epub 2014 Aug 29. No abstract available.

PMID:
25172845
19.

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D; Document Reviewers, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J, Valgimigli M, Zamorano JL.

Eur Heart J. 2014 Dec 1;35(45):3155-79. doi: 10.1093/eurheartj/ehu298. Epub 2014 Aug 25. No abstract available.

PMID:
25154388
20.

Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.

Lip GY, Laroche C, Boriani G, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Maggioni AP, Tavazzi L.

Europace. 2015 Feb;17(2):194-206. doi: 10.1093/europace/euu201. Epub 2014 Aug 21.

PMID:
25149078
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk